Assessing statin effects on cardiovascular pathways in HIV using a novel proteomics approach: Analysis of data from INTREPID, a randomized controlled trial
Mabel Toribio(Boston College), Steven Grinspoon(Massachusetts General Hospital), Craig A. Sponseller, Chris de Filippi(Alaska Heart and Vascular Institute), Lauren Stone, Janet Lo(Harvard University), Melanie Thompson(AIDS Research Consortium of Atlanta), Kathleen V. Fitch(Harvard University), Judith A. Aberg(Icahn School of Medicine at Mount Sinai), Markella V. Zanni(Harvard University), Hang Lee(Massachusetts General Hospital), Ida Grundberg(Olink (United States))
Cited by 25
Related Papers
An inflammatory cytokine signature predicts COVID-19 severity and survival
|Nature Medicine|2020|2.7k
Antiretroviral Treatment of Adult HIV Infection
|JAMA|2012|2.5k
Increased Acute Myocardial Infarction Rates and Cardiovascular Risk Factors among Patients with Human Immunodeficiency Virus Disease
|The Journal of Clinical Endocrinology & Metabolism|2007|1.6k
Cardiovascular Risk and Body-Fat Abnormalities in HIV-Infected Adults
|New England Journal of Medicine|2005|1.1k